Radiation Effects Research Foundation
The 14th meeting of the RERF Board of Councilors
Summary Report
The 14th meeting of the Board of Councilors (BOC) of the Radiation Effects Research Foundation(RERF) was held on June 19–20, 2024, at the Nagasaki Laboratory.
The following is a summary report of the major agenda items and results of discussions:
1．Report of activities and settlement of accounts
The status of activities in FY2023 was reported via the report of activities (including international
collaborative activities and joint projects with overseas institutions), settlement of accounts report,
audit report, and attached documents, and the reports were approved without objection.
2．Plans of activities/budgets and related matters
The FY2024 plans of activities and budgets for project implementation were reported, including
research projects examining the health of A-bomb survivors, research projects on the health of A-bomb
survivors’ children, research to elucidate individual radiation doses from the atomic bombing and theireffects, projects to collaborate with other scientific organizations and communicate research results,
training programs for domestic and overseas specialists, and public information programs.
3．RERF strategic plan and relocation plan
Regarding the strategic plan for achieving RERF’s goals and mission, discussions were held on thestatus of development of the Biosample Research Center (BRC) and the Research Resource Center(RRC), as well as on the status of preparations for the Trio Study to examine potential hereditaryeffects from radiation through the analysis of whole genome sequences of A-bomb survivors and theirchildren. RERF’s explanation on the progress of the plan for its relocation to the Kasumi Campus ofHiroshima University was followed by a discussion on the issue. RERF also reported a delay in theplan’s implementation.
4.

Recommendations of the Scientific Advisory Committee and RERF’s responses

Over three days, during March 12–14, 2024, the 51st meeting of the Scientific Advisory Committee(SAC) was held in person for the first time in five years. This year’s review focused on the Departmentof Molecular Biosciences. Status updates were also provided for cohort analyses and the Research
Resource Center (RRC). The SAC commended RERF for important improvements, including its
preparations for the Trio Study and the expanded research opportunities provided for young scientists.
Meanwhile, recommendations were made regarding the continued need to inventory biosamples,
address RERF’s organizational issues, and implement its strategic plan. Responses from RERF weresummarized and discussed, including planned improvements to its research infrastructure and strategicplan.
5.

Appointments of Councilors, Scientific Advisors, and Auditors

New Auditors, Councilors, and Scientific Advisors were appointed to replace those whose terms ofappointment expired at the end of the BOC meeting. Their terms of appointment will expire at theclose of the regular BOC meeting in the years indicated in parentheses in the attached document.

別 紙AttachmentႳ ʙ ỉ ᢠ ˓ᴾᵟᶎᶎᶍᶇᶌᶒᶋᶃᶌᶒᴾᶍᶄᴾᵟᶓᶂᶇᶒᶍᶐᴾᴾᴾ˓஖Ịίᴾ ᴾ ὸ࠰Ệ᧏͵ẰủỦ‫଺ܭ‬ᚸᜭՃ˟ỉኳኽỉ଺ộỂᴾᵲᶆᶃᴾᶒᶃᶐᶋᴾᶍᶄᴾᶍᶄᶄᶇᶁᶃᴾᶕᶇᶊᶊᴾᶀᶃᴾᶓᶌᶒᶇᶊᴾᶒᶆᶃᴾᶁᶍᶌᶁᶊᶓᶑᶇᶍᶌᴾᶍᶄᴾᶒᶆᶃᴾᵠᵭᵡᴾᶋᶃᶃᶒᶇᶌᶅᴾᵆᶐᶃᶅᶓᶊᵿᶐᵇᴾ
ᶆᶃᶊᶂᴾᶇᶌᴾᵆᴾ ᴾ ᵇᴾᶗᶃᵿᶐᵌᴾᴾᴾᴾ

ඕᴾ ᣼ᴾ ᴾ ᨙᴾᵫᶐᵌᴾᵲᵿᶉᵿᶑᶆᶇᴾᵩᶍᶆᶌᶍᴾ
ᵆᵐᵎᵐ8ᵇᴾᵫᶐᵌ ᵮᵿᶓᶊᴾᵮᶐᶃᶘᶇᶍᶒᶒᶇᴾ
ᵆᵐᵎᵐ8ᵇᴾ

評議員の選任
Appointment of Councilors
任期は（ ）年に開催される定時評議員会の終結の時まで
The term of office will be until the conclusion of the BOC meeting (regular) held in (佐 野 利 男（2029）
前原子力委員会委員・元軍縮会議日本政府代表部大使
Mr. Toshio Sano (2029)
Former Commissioner of Japan Atomic
Energy Commission and FormerAmbassador, Permanent Representativeof Japan to the Conference onDisarmament) year.

Dr. Angela Bies (2029)
米国メリーランド大学公共政策学部
世界的慈善および非営利事業リーダーシップ寄付講座 准教授
Endowed Associate Professor of Global
Philanthropy and Nonprofit Leadership,
School of Public Policy, University ofMaryland

早 野 龍 五（2025）

Dr. Jonathan M. Samet (2025)

東京大学名誉教授

米国コロラド大学公衆衛生学部 学部長

Dr. Ryugo Hayano (2025)
Emeritus Professor, The University ofTokyo

Dean, School of Public Health, Universityof Colorado

米 倉 義 晴（2026）
大阪大学放射線科学基盤機構 招へい教授

Dr. Joe W. Gray (2026)
米国オレゴン健康科学大学およびカリフォルニア大学サンフランシスコ校名誉教授

Dr. Yoshiharu Yonekura (2026)
Guest Professor,Institute for Radiation Sciences,Osaka University

小 林 正 夫（2027）
日本赤十字社中四国ブロック血液センター
相談役
Dr. Masao Kobayashi（2027）
Consultant, Japanese Red Cross ChugokuShikoku Block Blood Center

Professor Emeritus, Oregon Health andScience University and the University ofCalifornia, San Francisco
Dr. Keith R. Yamamoto (2027)
米国カリフォルニア大学サンフランシスコ校
教授、科学政策・戦略担当副総長、精密医療担当部長
Professor, Vice Chancellor for Science
Policy and Strategy, Director UCSF
Precision Medicine

科学諮問委員の選任
Appointment of Scientific Advisors
任期は（ ）年に開催される定時評議員会の終結の時まで
The term of office will be until the conclusion of the BOC meeting (regular) held in (松田 文彦 (2029)
京都大学大学院医学研究科附属ゲノム医学センター長) year.

Dr. Melissa Haendel (2029)

Dr. Fumihiko Matsuda (2029)

ノースカロライナ大学チャペルヒル校
精密医療トランスレーショナルインフォマ
ティクス学部長

Director, Center for Genomic Medicine,
Kyoto University Graduate School ofMedicine

Director of Precision Health &Translational Informatics, University ofNorth Carolina

永田 知里 (2025)
岐阜大学大学院医学系研究科
疫学・予防医学分野 教授

Dr. Jonine Bernstein (2025)
米国スローン・ケタリング記念がんセンター
生存・転帰・リスクプログラム担当疫学者兼共同リーダー

Dr. Chisato Nagata (2025)
Professor, Department of Epidemiology andPreventive Medicine, Gifu University
Graduate School of Medicine

鈴木 元 （2026）
医療法人保内郷厚生会保内郷メディカルク
リニック医師Dr. Gen Suzuki (2026)
Medical Doctor, Honaigo Medical Clinic,
Honaigo Koseikai Medical Corporation

Attending Epidemiologist, Co-Program
Leader Survivorship, Outcomes and Risk
Program, Memorial Sloan Kettering Cancer
CenterDr. Nilanjan Chatterjee (2026)
米国ジョンズ・ホプキンズ大学医学部
ブルームバーグ公衆衛生大学院 腫瘍学部
生物統計学科 ブルームバーグ 特別教授
Bloomberg Distinguished Professor,
Department of Biostatistics, Bloomberg
School of Public Health and Department ofOncology, School of Medicine, Johns
Hopkins University

島田 義也 （2027）

Dr. Gayle E. Woloschak (2027)

公益財団法人 環境科学技術研究所 理事長
President, Institute for Environmental
Sciences

米国ノースウェスタン大学フェインバーグ
医学研究科 放射線腫瘍学部 教授
Professor, Departments of Radiation
Oncology, Feinberg School of Medicine,Northwestern University

今岡 達彦 (2028)

Dr. Patrick Concannon (2028)

国立研究開発法人 量子科学技術研究開発
機構 量子生命・医学部門 放射線医学研究
所 放射線影響研究部 修飾要因・幹細胞研
究グループ グループリーダー

米国フロリダ大学医学部 病理学・免疫学・臨床検査医学科 名誉教授

Dr. Yoshiya Shimada (2027)

Dr. Tatsuhiko Imaoka (2028)
Group Leader, Modifying Factor/Stem Cell
Research Group, Department of Radiation
Effects Research, National Institute ofRadiological Sciences, Quantum Life andMedical Science Directorate, National
Institute for Quantum Science andTechnology

Professor Emeritus, Department ofPathology, Immunology and Laboratory
Medicine, College of Medicine, University ofFlorida